Abstract
Summary: Mitochondrial oxidative phosphorylation (OXPHOS) is fundamental in all aspects of cellular life in aerobic cells and organisms. It is therefore not surprising that a variety of diseases have been attributed to dysfunction of the OXPHOS enzymes. Assessment of OXPHOS in human samples has proved to be a difficult task over years, even when relying on well-established methods. The complexity and the flexibility of the mitochondrial organization in cells account for a large part in the difficulties encountered in assessing OXPHOS activity. Nevertheless, a careful and detailed analysis of OXPHOS enzyme activity in cells or biopsy samples from patients at risk provides ↑ diagnosis of potential OXPHOS deficiency. Problems inherent in the use of human material, mostly the small size of the samples to be analysed, are difficult to resolve. However, cautious handling of these samples permits reasonable confidence to be reached in the interpretation of the data.
Similar content being viewed by others
REFERENCES
Bourgeron T, Chretien D, R6tig A, Munnich A, Rustin P (1993) Fate and expression of the deleted mitochondrial DNA differ between heteroplasmic skin fibroblast and Epstein-Barr virus-transformed lymphocyte cultures. J Biol Chem 268: 19369-19376.
Chretien D, Gallego J, Barrientos A, et al (1997) The biochemical parameters for the diagnosis of respiratory chain deficiency in man and their lack of age-related changes. Biochem J 329: 249-254.
Geromel V, Kadhom N, Ceballos-Picot I, et al (2001) Superoxide-induced massive apoptosis in cultured skin fibroblasts harboring the neurogenic ataxia retinitis pigmentosa (NARP) mutation in the ATPase-6 gene of the mitochondrial DNA. Hum Mol Genet 10: 1221-1228.
Geromel V, Darin N, Chretien D, et al (2002) Coenzyme Q1o and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits. Mol Genet Metab 71: 21-30.
Larsson NG, Clayton DA (1995) Molecular genetic aspects of human molecular disorders. Annu Rev Genet 29: 151-178.
Munnich A, Rustin P (2001) Clinical spectrum and diagnosis of mitochondrial disorders. Am J Med Genet 106: 417.
Munnich A, Rötig A, Cormier-Daire V, Rustin P (2001) Clinical presentation of respiratory chain deficiency. In Scriver C, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Metabolic Disease 8th edn. New York: McGraw-Hill, 2261-2274.
Nicholls DG (1982) Bioenergetics: An Introduction to the Chemiosmotic Theory. New York: Academic Press.
Raha S, Robinson BH (2001) Mitochondria, oxygen free radicals, and apoptosis. Am J Med Genet 106: 62-70.
Romero NB, Lombes A, Touati G, et al (1996) Morphological studies of skeletal muscle in lactic acidosis. J Inherit Metab Dis 19: 528-534.
Rustin P (2002) Mitochondria, from cell death to proliferation. Nature Genetics 30: 352-353.
Rustin P, Chretien D, Bourgeron T, et al (1991) An improved representation of enzyme activi-ties for assessment of the mitochondrial respiratory chain. Lancet 338: 60.
Rustin P, Chretien D, Gerard B, et al (1994) Biochemical and molecular investigations in res-piratory chain deficiencies. Clin Chim Acta 228: 35-51.
Rustin P, Parfait B, Chretien D, et al (1996) Fluxes of nicotinamide adenine dinucleotides through mitochondrial membranes in human cultured cells. J Biol Chem 271: 14785-14790.
Tyler D (1992) The Mitochondrion in Health and Disease. New York: VCH.
Tzagoloff A (1982) Mitochondria. New York: Plenum Press.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chretien, D., Rustin, P. Mitochondrial oxidative phosphorylation: Pitfalls and tips in measuring and interpreting enzyme activities. J Inherit Metab Dis 26, 189–198 (2003). https://doi.org/10.1023/A:1024437201166
Issue Date:
DOI: https://doi.org/10.1023/A:1024437201166